NICOLE OUELLETTE: Open Payments
NPI 1568975969 · FOXBORO, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,779 in 208 payments from 32 companies in 2025. Trend: 2023 $4,997 · 2024 $5,621 · 2025 $4,779
Food & beverage: $4,779
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $608 |
| Lundbeck LLC | 20 | $425 |
| PFIZER INC. | 15 | $336 |
| SK Life Science, Inc. | 13 | $332 |
| Biogen, Inc. | 16 | $314 |
| Lilly USA, LLC | 11 | $266 |
| Merz Pharmaceuticals, LLC | 8 | $262 |
| Novartis Pharmaceuticals Corporation | 12 | $232 |
| Amneal Pharmaceuticals LLC | 12 | $210 |
| EMD Serono, Inc. | 8 | $194 |
Products named: QULIPTA, VYEPTI, NURTEC ODT, Xeomin, KISUNLA, KESIMPTA, TYSABRI, ONGENTYS.
Industry payments across MA — which companies pay providers there.
